143
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEClinical Translational Therapeutics

Obesity and Microvascular Invasion in Hepatocellular Carcinoma

, , , , , , , , , , , , , & show all
Pages 1063-1069 | Published online: 15 Nov 2010

REFERENCES

  • Altekruse, S.F.; Kosary, C.L.; Krapcho, M.; Neyman, N.; Aminou, R.; Waldron, W.; Ruhl, J.; Howlader, N.; Tatalovich, Z.; Cho, H.; Mariotto, A.; Eisner, M.P.; Lewis, D.R.; Cronin, K.; Chen, H.S.; Feuer, E.J.; Stinchcomb, D.G.; Edwards, B.K. (eds) SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/. Based on November 2009 SEER data submission, posted to the SEER web site, 2010.
  • Caldwell, S.H.; Oelsner, D.H.; Iezzoni, J.C.; Hespenheide, E.E.; Battle, E.H.; Driscoll, C.J. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29, 664–669.
  • Adams, L.A.; Lindor, K.D. Nonalcoholic fatty liver disease. Ann Epidemiol 2007, 17, 863–869.
  • Farrell, G.C.; Larter, C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43, S99–S112.
  • Siegel, A.B.; Zhu, A.X. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 2009, 115(24), 5651–5661.
  • Ford, E.S.; Giles, W.H.; Mokdad, A.H. Increasing prevalence of the metabolic syndrome among US Adults. Diabetes Care 2004, 27, 2444–2449.
  • Clark, J.M.; Brancati, F.L.; Diehl, A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003, 98, 960–967.
  • Wong, J.B.; McQuillan, G.M.; McHutchison, J.G.; Poynard, T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000, 90, 1562–1569.
  • Browning, J.D.; Szczepaniak, L.S.; Dobbins, R; Nuremberg, P.; Horton, J.D.; Cohen, J.C.; Grundy, S.M.; Hobbs, H.H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40, 1387–1395.
  • Zelber-Sagi, S.; Nitzan-Kaluski, D.; Halpern, Z.; Oren, R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006, 26, 856–863.
  • Bedogni, G.; Miglioli, L.; Masutti, F.; Tiribelli, C.; Marchesini, G; Bellentani, S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42, 44–52.
  • Matteoni, C.A.; Younossi, Z.M.; Gramlich, T.; Boparai, N.; Liu, Y.C.; McCullough, A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116, 1413–1419.
  • Ratziu, V.; Bonyhay, L.; Di Martino, V.; Charlotte, F.; Cavallaro, L.; Sayegh-Tainturier, M.H.; Giral, P.; Grimaldi, A.; Opolon, P.; Poynard, T. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35, 1485–1493.
  • Pekow, J.R.; Bhan, A.K.; Zheng, H.; Chung, R.T. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 2007, 109(12), 2490–2496.
  • Gonzalez, L.; Blanc, J.F.; Sa Cunha, A.; Rullier, A.; Saric, J.; Le Bail, B.; Balabaud, C.; Bioulac-Sage, P. Obesity as a risk factor for hepatocellular carcinoma in a noncirrhotic patient. Semin Liver Dis 2004, 24, 415–419.
  • Calle, E.E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003, 348, 1625–1638.
  • Iannaccone, R.; Piacentini, F.; Murakami, T.; Paradis, V.; Belghiti, J.; Hori, M.; Kim, T.; Durand, F.; Wakasa, K.; Monden, M.; Nakamura, H.; Passariello, R.; Vilgrain, V. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 2007, 243, 422–430.
  • Yao, D.F.; Wu, X.H.; Zhu, Y.; Shi, G.S.; Dong, Z.Z.; Yao, D.B.; Wu, W.; Qiu, L.W.; Meng, X.Y. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int2005, 4, 220–226.
  • Myers, M.G.; Cowley, M.A.; Munzberg, H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 2008, 70, 537–556.
  • Sierra-Honigmann, M.R.; Nath, A.K.; Murakami, C.; García-Cardeña, G.; Papapetropoulos, A.; Sessa, W.C.; Madge, L.A.; Schechner, J.S.; Schwabb, M.B.; Polverini, P.J.; Flores-Riveros, J.R. Biological action of leptin as an angiogenic factor. Science 1998, 281, 1683–1686.
  • Aleffi, S.; Petrai, I.; Bertolani, C.; Parola, M.; Colombatto, S.; Novo, E.; Vizzutti, F.; Anania, F.A.; Milani, S.; Rombouts, K.; Laffi, G.; Pinzani, M.; Marra, F. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005, 42, 1339–1348.
  • Kitade, M.; Yoshiji, H.; Kojima, H.; Ikenaka, Y.; Noguchi, R.; Kaji, K.; Yoshii, J.; Yanase, K.; Namisaki, T.; Asada, K.; Yamazaki, M.; Tsujimoto, T.; Akahane, T.; Uemura, M.; Fukui, H. Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. Hepatology 2006, 44, 983–991.
  • Dall'Oglio, M.F.; Ribeiro-Filho, L.A.; Antunes, A.A.; Crippa, A.; Nesrallah, L.; Gonçalves, P.D.; Leite, K.R.; Srougi, M. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. J Urol 2007, 178, 425–428; discussion 8.
  • Lei, H.J.; Chau, G.Y.; Lui, W.Y.; Tsay, S.H.; King, K.L.; Loong, C.C.; Wu, C.W. Prognostic value and clinical relevance of the 6th edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 2006, 203, 426–435.
  • Acenero, M.J.; Gonzalez, J.F.; Gallego, M.G.; Ballesteros, P.A. Vascular enumeration as a significant prognosticator for invasive breast carcinoma. J Clin Oncol 1998, 16, 1684–1688.
  • Mazzaferro, V.; Regalia, E.; Doci, R.; Andreola, S.; Pulvirenti, A.; Bozzetti, F.; Montalto, F.; Ammatuna, M.; Morabito, A.; Gennari, L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334, 693–699.
  • Jonas, S.; Bechstein, W.O.; Steinmüller, T.; Herrmann, M.; Radke, C.; Berg, T.; Settmacher, U.; Neuhaus, P. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001, 33, 1080–1086.
  • Marsh, J.W.; Dvorchik, I.; Bonham, C.A.; Iwatsuki, S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000, 88, 538–543.
  • Esnaola, N.F.; Lauwers, G.Y.; Mirza, N.Q.; Nagorney, D.M.; Doherty, D.; Ikai, I.; Yamaoka, Y.; Regimbeau, J.M.; Belghiti, J.; Curley, S.A.; Ellis, L.M.; Vauthey, J.N. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002, 6, 224–232; discussion 32.
  • Parfitt, J.R.; Marotta, P.; Alghamdi, M.; Wall, W.; Khakhar, A.; Suskin, N.G.; Quan, D.; McAllister, V.; Ghent, C.; Levstik, M.; McLean, C.; Chakrabarti, S.; Garcia, B.; Driman, D.K. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl 2007, 13, 543–551.
  • Pugh, R.; Murray-Lyon, I.; Dawson, J.; Pietroni, M.C.; Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60(8), 646–649.
  • Kleiner, D.E.; Brunt, E.M.; Van Natta, M.; Behling, C.; Contos, M.J.; Cummings, O.W.; Ferrell, L.D.; Liu, Y.C.; Torbenson, M.S.; Unalp-Arida, A.; Yeh, M.; McCullough, A.J.; Sanyal, A.J.; Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313–1321.
  • Rega, G.; Kaun, C.; Demyanets, S.; Pfaffenberger, S.; Rychli, K.; Hohensinner, P.J.; Kastl, S.P.; Speidl, W.S.; Weiss, T.W.; Breuss, J.M.; Furnkranz, A.; Uhrin, P.; Zaujec, J.; Zilberfarb, V.; Frey, M.; Roehle, R.; Maurer, G.; Huber, K.; Wojta, J. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin M in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1587–95.
  • Horiguchi, A.; Sumitomo, M.; Asakuma, J.; Asano, T.; Zheng, R.; Asano, T.; Nanus, D.M.; Hayakawa, M. Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J Urol 2006, 176, 1631–1635.
  • Kanda, M.; Nomoto, S.; Nishikawa, Y.; Sugimoto, H.; Kanazumi, N.; Takeda, S.; Nakao, A. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J Surg Oncol 2008, 98, 190–196.
  • Amaoka, N.; Osada, S.; Kanematsu, M.; Imai, H.; Tomita, H.; Tokuyama, Y.; Sakashita, F.; Nonaka, K.; Goshima, S.; Kondo, H.; Adachi, Y. Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression. J Gastroenterol Hepatol 2007, 22, 2202–2207.
  • Wang, Y.D.; Wu, P.; Mao, J.D.; Huang, H.; Zhang, F. Relationship between vascular invasion and microvessel density and micrometastasis. World J Gastroenterol 2007, 13, 6269–6273.
  • Li, S.G.; Ye, Z.Y.; Zhao, Z.S.; Tao, H.Q.; Wang, Y.Y.; Niu, C.Y. Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma. World J Gastroenterol 2008, 14, 421–427.
  • Thiebaut, A.C.; Benichou, J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004, 23, 3803–3820.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.